share_log

公告精选 | 康宁医院前三季门诊均次总开支同比增1.4%;百济神州:授出购股权及受限制股份单位

Selected announcements | KN Hospital's total outpatient cost per visit in the first three quarters increased by 1.4% year-on-year; Beigene: granted share purchase rights and restricted share units.

cls.cn ·  08:25

Important announcements in Hong Kong stocks today:

1) Company News

Beigene: Grants stock options and restricted stock units

$BEIGENE (06160.HK)$ Announcement: On September 30, 2024, the Board of Directors and/or the Compensation Committee granted a total of 0.0227 million American Depositary Shares options to twelve grantees and issued a total of 0.0905 million restricted stock units involving the American Depositary Shares to two hundred and twenty-three grantees in accordance with the terms of the 2016 Options and Incentive Plan.

$KN HOSPITAL (02120.HK)$: The average total cost per bed day in the first three quarters is 367 yuan, a decrease of 5.7% year-on-year; the number of outpatient visits is approximately 0.3693 million, a decrease of 2.5% year-on-year; and the average total cost per outpatient visit is 433 yuan, an increase of 1.4% year-on-year.

Cu Venture Inv: Postponement of the publication of the 2023/2024 annual performance, continues to suspend trading

$CU VENTURE INV (08159.HK)$ Announcement: The company currently expects the audited annual performance for the fifteen months ending March 31, 2024 (full-year performance for 2023/2024) and the annual report for 2023/2024 to be published and distributed between mid-November and the end of December 2024. The company is making every effort to meet the conditions stated in the resumption guidance, including the announcement and publication of the audited annual performance for the fifteen months ending March 31, 2024, and the annual report, and is closely cooperating with internal and/or external parties to promote the implementation of the resumption proposal to meet the requirements set by the Hong Kong Stock Exchange.

Brainhole Technology spent approximately $3 million to purchase a total of 0.396 million shares of Up Fintech.

$BRAINHOLE TECH (02203.HK)$ Announcement: On October 2, 2024, the company purchased a total of 0.396 million shares of Up Fintech on the open market at a total cost of approximately $3 million (equivalent to approximately HK$23 million) (excluding transaction costs); purchased a total of 0.147 million shares of Ke Holdings at a total cost of approximately HK$10 million (excluding transaction costs); purchased a total of 0.0418 million shares of Ke Holdings' American Depositary Shares at a total cost of approximately $100 million (equivalent to approximately HK$8 million) (excluding transaction costs). In addition, the company sold a total of 0.0336 million shares of Micron shares on the open market for a total price of approximately $3.4 million (equivalent to approximately HK$26.4 million) (excluding transaction costs).

$JINGRUI HLDGS (01862.HK)$The cumulative contract sales in the first 9 months were 1.466 billion yuan, a decrease of 53.49% year-on-year. Among them, the contract sales in September were 0.13 billion yuan, a decrease of 37.2% year-on-year.

$BAUHAUS INT'L (00483.HK)$In the third quarter, same-store sales of self-operated physical stores increased by 1% year-on-year.

2) Financing and Repurchase Dynamics

$TIANGE (01980.HK)$The board of directors has approved a budget to repurchase shares on the open market for up to 0.2 billion Hong Kong dollars within a period of three years from the date of this announcement.

$TENCENT (00700.HK)$Investing approximately 0.251 billion Hong Kong dollars to repurchase 0.5492 million shares at a repurchase price of 453.40-459.40 Hong Kong dollars.

$SWIRE PACIFIC A (00019.HK)$Investing 27.4612 million Hong Kong dollars to repurchase 0.3995 million shares at a repurchase price of 10.56-10.84 Hong Kong dollars.

$SIRNAOMICS-B (02257.HK)$Proposed to discount 20% for the subscription of 17.5277 million shares, raising approximately 58.5 million Hong Kong dollars net.

Editor/Lambor

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment